Annual Operating Expenses
$13.12 M
+$2.75 M+26.55%
December 31, 2023
Summary
- As of February 7, 2025, SBFM annual total operating expenses is $13.12 million, with the most recent change of +$2.75 million (+26.55%) on December 31, 2023.
- During the last 3 years, SBFM annual operating expenses has risen by +$12.50 million (+2008.69%).
- SBFM annual operating expenses is now at all-time high.
Performance
SBFM Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$3.97 M
+$348.00 K+9.60%
September 30, 2024
Summary
- As of February 7, 2025, SBFM quarterly total operating expenses is $3.97 million, with the most recent change of +$348.00 thousand (+9.60%) on September 30, 2024.
- Over the past year, SBFM quarterly operating expenses has increased by +$1.20 million (+43.43%).
- SBFM quarterly operating expenses is now -39.15% below its all-time high of $6.53 million, reached on December 31, 2022.
Performance
SBFM Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
SBFM Operating Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +26.6% | +43.4% |
3 y3 years | +2008.7% | +33.9% |
5 y5 years | +1027.2% | +33.9% |
SBFM Operating Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +414.6% | -39.1% | +1208.9% |
5 y | 5-year | at high | +2008.7% | -39.1% | +8747.4% |
alltime | all time | at high | >+9999.0% | -39.1% | >+9999.0% |
Sunshine Biopharma Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $3.97 M(+9.6%) |
Jun 2024 | - | $3.62 M(-2.2%) |
Mar 2024 | - | $3.70 M(-1.3%) |
Dec 2023 | $13.12 M(+26.6%) | $3.76 M(+35.6%) |
Sep 2023 | - | $2.77 M(-6.6%) |
Jun 2023 | - | $2.97 M(-18.9%) |
Mar 2023 | - | $3.66 M(-44.0%) |
Dec 2022 | $10.37 M(+306.6%) | $6.53 M(+265.7%) |
Sep 2022 | - | $1.78 M(+131.4%) |
Jun 2022 | - | $771.40 K(-40.0%) |
Mar 2022 | - | $1.29 M(+323.8%) |
Dec 2021 | $2.55 M(+309.8%) | - |
Dec 2021 | - | $303.50 K(-42.4%) |
Sep 2021 | - | $527.10 K(+24.6%) |
Jun 2021 | - | $423.00 K(-67.4%) |
Mar 2021 | - | $1.30 M(+259.4%) |
Dec 2020 | $622.40 K(-4.5%) | $360.90 K(+362.1%) |
Sep 2020 | - | $78.10 K(-43.7%) |
Jun 2020 | - | $138.60 K(+208.7%) |
Mar 2020 | - | $44.90 K(-82.5%) |
Dec 2019 | $651.70 K(-44.0%) | $257.00 K(+25.5%) |
Sep 2019 | - | $204.70 K(+201.9%) |
Jun 2019 | - | $67.80 K(-44.6%) |
Mar 2019 | - | $122.30 K(-14.9%) |
Dec 2018 | $1.16 M(+35.8%) | $143.70 K(-50.2%) |
Sep 2018 | - | $288.80 K(-50.2%) |
Jun 2018 | - | $580.50 K(+269.7%) |
Mar 2018 | - | $157.00 K(-3.2%) |
Dec 2017 | $857.20 K(-13.7%) | $162.20 K(+42.5%) |
Sep 2017 | - | $113.80 K(-75.9%) |
Jun 2017 | - | $472.20 K(+333.2%) |
Mar 2017 | - | $109.00 K(-67.6%) |
Dec 2016 | $993.10 K | $336.10 K(+189.7%) |
Sep 2016 | - | $116.00 K(-75.4%) |
Jun 2016 | - | $471.30 K(+576.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2016 | - | $69.70 K(-60.0%) |
Dec 2015 | $782.00 K(-55.4%) | $174.20 K(+54.0%) |
Sep 2015 | - | $113.10 K(-69.4%) |
Jun 2015 | - | $369.90 K(+196.4%) |
Mar 2015 | - | $124.80 K(-59.3%) |
Dec 2014 | $1.76 M(-9.3%) | $306.30 K(+10.4%) |
Sep 2014 | - | $277.40 K(-63.8%) |
Jun 2014 | - | $765.50 K(+88.6%) |
Mar 2014 | - | $405.90 K(-40.8%) |
Dec 2013 | $1.94 M(+174.0%) | $685.40 K(+285.7%) |
Sep 2013 | - | $177.70 K(+16.4%) |
Jun 2013 | - | $152.60 K(-83.5%) |
Mar 2013 | - | $922.90 K(+390.1%) |
Dec 2012 | $706.70 K(+27.1%) | $188.30 K(-50.0%) |
Sep 2012 | - | $376.40 K(+266.5%) |
Jun 2012 | - | $102.70 K(+161.3%) |
Mar 2012 | - | $39.30 K(-89.4%) |
Dec 2011 | $556.20 K(+3.5%) | $372.10 K(+219.7%) |
Sep 2011 | - | $116.40 K(+605.5%) |
Jun 2011 | - | $16.50 K(-66.5%) |
Mar 2011 | - | $49.20 K(-88.5%) |
Dec 2010 | $537.40 K(+437.4%) | $426.90 K(+166.1%) |
Sep 2010 | - | $160.40 K(-89.9%) |
Jun 2010 | - | $1.59 M(+4489.9%) |
Mar 2010 | - | $34.60 K(+8.1%) |
Dec 2009 | $100.00 K(+536.9%) | - |
Oct 2009 | - | $32.00 K(+515.4%) |
Jul 2009 | $15.70 K(-39.8%) | $5200.00(+108.0%) |
Apr 2009 | - | $2500.00(-26.5%) |
Jan 2009 | - | $3400.00(-26.1%) |
Oct 2008 | - | $4600.00(+9.5%) |
Jul 2008 | $26.10 K(+99.2%) | $4200.00(-61.1%) |
Apr 2008 | - | $10.80 K(+369.6%) |
Jan 2008 | - | $2300.00(-73.9%) |
Oct 2007 | - | $8800.00 |
Jul 2007 | $13.10 K | - |
FAQ
- What is Sunshine Biopharma annual total operating expenses?
- What is the all time high annual operating expenses for Sunshine Biopharma?
- What is Sunshine Biopharma annual operating expenses year-on-year change?
- What is Sunshine Biopharma quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly operating expenses year-on-year change?
What is Sunshine Biopharma annual total operating expenses?
The current annual operating expenses of SBFM is $13.12 M
What is the all time high annual operating expenses for Sunshine Biopharma?
Sunshine Biopharma all-time high annual total operating expenses is $13.12 M
What is Sunshine Biopharma annual operating expenses year-on-year change?
Over the past year, SBFM annual total operating expenses has changed by +$2.75 M (+26.55%)
What is Sunshine Biopharma quarterly total operating expenses?
The current quarterly operating expenses of SBFM is $3.97 M
What is the all time high quarterly operating expenses for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly total operating expenses is $6.53 M
What is Sunshine Biopharma quarterly operating expenses year-on-year change?
Over the past year, SBFM quarterly total operating expenses has changed by +$1.20 M (+43.43%)